|
|
 |
|
Total Number of Holdings (excluding cash): 50
| WuXi AppTec Co., Ltd. (Class H) |
2359.HK |
Y971B1118 |
5,685 |
$51,255.71 |
2.52% |
| DexCom, Inc. |
DXCM |
252131107 |
553 |
$47,928.51 |
2.36% |
| Sartorius Stedim Biotech |
DIM.FP |
F8005V210 |
212 |
$46,782.81 |
2.30% |
| Demant A/S |
DEMANT.DC |
K3008M105 |
1,122 |
$46,617.48 |
2.29% |
| Exact Sciences Corporation |
EXAS |
30063P105 |
850 |
$46,639.50 |
2.29% |
| Insulet Corporation |
PODD |
45784P101 |
148 |
$46,141.96 |
2.27% |
| Smith & Nephew Plc |
SN/.LN |
G82343164 |
2,997 |
$45,609.45 |
2.24% |
| Hoya Corporation |
7741.JP |
J22848105 |
394 |
$44,827.89 |
2.20% |
| ResMed Inc. |
RMD |
761152107 |
177 |
$44,639.40 |
2.20% |
| Amplifon SpA |
AMP.IM |
T0388E118 |
1,873 |
$44,032.16 |
2.17% |
| Mettler-Toledo International Inc. |
MTD |
592688105 |
37 |
$43,820.58 |
2.15% |
| Agilent Technologies, Inc. |
A |
00846U101 |
372 |
$43,077.60 |
2.12% |
| Carl Zeiss Meditec AG (Bearer) |
AFX.GY |
D14895102 |
624 |
$42,735.82 |
2.10% |
| GE HealthCare Technologies Inc. |
GEHC |
36266G107 |
597 |
$42,757.14 |
2.10% |
| Edwards Lifesciences Corporation |
EW |
28176E108 |
545 |
$42,248.40 |
2.08% |
| Intuitive Surgical, Inc. |
ISRG |
46120E602 |
76 |
$42,338.08 |
2.08% |
| Masimo Corporation |
MASI |
574795100 |
246 |
$42,304.62 |
2.08% |
| BioMerieux |
BIM.FP |
F1149Y232 |
303 |
$42,124.56 |
2.07% |
| Align Technology, Inc. |
ALGN |
016255101 |
232 |
$41,903.84 |
2.06% |
| Hologic, Inc. |
HOLX |
436440101 |
651 |
$41,878.83 |
2.06% |
| Steris Plc |
STE |
G8473T100 |
171 |
$41,676.12 |
2.05% |
| Straumann Holding AG (Registered) |
STMN.SW |
H8300N127 |
321 |
$41,689.58 |
2.05% |
| Waters Corporation |
WAT |
941848103 |
118 |
$41,438.06 |
2.04% |
| Fisher & Paykel Healthcare Corporation Limited |
FPH.NZ |
Q38992105 |
1,881 |
$41,327.71 |
2.03% |
| Sonova Holding AG (Registered) |
SOON.SW |
H8024W106 |
132 |
$41,176.22 |
2.02% |
| Stryker Corporation |
SYK |
863667101 |
107 |
$41,076.23 |
2.02% |
| West Pharmaceutical Services, Inc. |
WST |
955306105 |
183 |
$41,118.27 |
2.02% |
| Boston Scientific Corporation |
BSX |
101137107 |
401 |
$40,938.09 |
2.01% |
| Siemens Healthineers AG |
SHL.GY |
D6T479107 |
766 |
$40,720.54 |
2.00% |
| Cochlear Limited |
COH.AU |
Q25953102 |
232 |
$40,466.49 |
1.99% |
| Danaher Corporation |
DHR |
235851102 |
206 |
$40,380.12 |
1.99% |
| Baxter International Inc. |
BAX |
071813109 |
1,322 |
$40,003.72 |
1.97% |
| Abbott Laboratories |
ABT |
002824100 |
299 |
$39,940.42 |
1.96% |
| Olympus Corporation |
7733.JP |
J61240107 |
2,940 |
$39,592.10 |
1.95% |
| Medtronic Plc |
MDT |
G5960L103 |
451 |
$39,435.44 |
1.94% |
| Koninklijke Philips N.V. |
PHIA.NA |
N7637U112 |
1,655 |
$38,926.09 |
1.91% |
| Merit Medical Systems, Inc. |
MMSI |
589889104 |
406 |
$38,683.68 |
1.90% |
| Alcon Inc. |
ALC.SW |
H01301128 |
428 |
$37,501.74 |
1.84% |
| Revvity, Inc. |
RVTY |
714046109 |
400 |
$36,788.00 |
1.81% |
| Penumbra, Inc. |
PEN |
70975L107 |
138 |
$35,728.20 |
1.76% |
| The Cooper Companies, Inc. |
COO |
216648501 |
493 |
$35,658.69 |
1.75% |
| Teleflex Incorporated |
TFX |
879369106 |
288 |
$35,366.40 |
1.74% |
| Bio-Rad Laboratories, Inc. (Class A) |
BIO |
090572207 |
160 |
$35,107.20 |
1.73% |
| Thermo Fisher Scientific Inc. |
TMO |
883556102 |
87 |
$34,965.30 |
1.72% |
| Coloplast A/S (Class B) |
COLOB.DC |
K16018192 |
360 |
$34,622.15 |
1.70% |
| Terumo Corporation |
4543.JP |
J83173104 |
1,860 |
$33,468.07 |
1.65% |
| Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
364 |
$33,626.32 |
1.65% |
| Becton, Dickinson and Company |
BDX |
075887109 |
187 |
$32,435.15 |
1.60% |
| Globus Medical, Inc. (Class A) |
GMED |
379577208 |
524 |
$31,398.08 |
1.54% |
| Sysmex Corporation |
6869.JP |
J7864H102 |
1,934 |
$31,333.66 |
1.54% |
| US Dollar |
$USD |
|
7,782 |
$7,782.47 |
0.38% |
| Japanese Yen |
$JPY |
|
64,639 |
$446.25 |
0.02% |
| Euro |
$EUR |
|
0 |
$0.06 |
0.00% |
| Pound Sterling |
$GBP |
|
0 |
$0.15 |
0.00% |
| Yuan Renminbi |
$CNY |
|
-757 |
($105.26) |
-0.01% |
| Hong Kong Dollar |
$HKD |
|
-7,335 |
($934.73) |
-0.05% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|